Insilico Medicine Successfully Discovered Potent, Selective, and Orally Bioavailable Small Molecule Inhibitor of CDK8 Using Generative AI
Abu Dhabi, April 24, 2023 (GLOBE NEWSWIRE) — Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company which operates the largest AI-powered